litlas
Log inCreate account

Réda Bouabdallah

Active 1995–2022

Also published as
Reda Bouabdallah
72
Papers
19,659
Citations
56
h-index
72
i10-index

Citations

Citations per year for Réda Bouabdallah1992: 1 citations1995: 1 citations1996: 3 citations1997: 8 citations1998: 11 citations1999: 13 citations2000: 10 citations2001: 15 citations2002: 27 citations2003: 89 citations2004: 60 citations2005: 82 citations2006: 101 citations2007: 132 citations2008: 140 citations2009: 103 citations2010: 119 citations2011: 142 citations2012: 139 citations2013: 116 citations2014: 124 citations2015: 126 citations2016: 101 citations2017: 137 citations2018: 116 citations2019: 390 citations2020: 486 citations2021: 466 citations2022: 411 citations2023: 238 citations2024: 353 citations2025: 128 citations2026: 2 citations1993–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,636 citing papers, 23.2% of this breakdownFrance: 610 citing papers, 8.7% of this breakdownGermany: 489 citing papers, 6.9% of this breakdownItaly: 464 citing papers, 6.6% of this breakdownUnited Kingdom: 446 citing papers, 6.3% of this breakdownChina: 353 citing papers, 5% of this breakdownCanada: 291 citing papers, 4.1% of this breakdownSwitzerland: 274 citing papers, 3.9% of this breakdownSpain: 260 citing papers, 3.7% of this breakdownAustralia: 205 citing papers, 2.9% of this breakdownNetherlands: 201 citing papers, 2.9% of this breakdownBelgium: 160 citing papers, 2.3% of this breakdown
0%23.2%Other 23.5%

Institutions

Fields

  • Medicine88.3%
  • Biochemistry, Genetics and Molecular Biology6%
  • Immunology and Microbiology4.6%
  • Materials Science0.3%
  • Computer Science0.2%
  • Neuroscience0.1%
  • Other0.5%

Topics

  • Lymphoma Diagnosis and Treatment20.6%
  • CAR-T cell therapy research6.7%
  • Chronic Lymphocytic Leukemia Research6.2%
  • CNS Lymphoma Diagnosis and Treatment5.7%
  • Viral-associated cancers and disorders5.4%
  • Immune Cell Function and Interaction3.1%
  • Other52.3%

Coauthors

All papers

Open in search
  1. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

    Authors: Bertrand Coiffier, Éric Lepage, Josette Brière, Raoul Herbrecht, Hervé Tilly, Réda Bouabdallah, Pierre Morel, Éric Van Den Neste, Gilles Salles, Philippe Gaulard, Félix Reyes, P Lederlin, Christian Gisselbrecht - New England Journal of Medicine 2002 cited by 5,562

  2. Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial

    Authors: Nagesh Kalakonda, Marie Maerevoet, Federica Cavallo, George Follows, André Goy, Joost S.P. Vermaat, Olivier Casasnovas, Nada Hamad, Josée M. Zijlstra, Sameer Bakhshi, Réda Bouabdallah, Sylvain Choquet, Ronit Gurion, Brian T. Hill, Ulrich Jaeger, Juan‐Manuel Sancho, Michael Schuster, Catherine Thiéblemont, Fátima De la Cruz, Miklós Egyed, Sourav Mishra, Fritz Offner, Theodoros P. Vassilakopoulos, Krzysztof Warzocha, Daniel McCarthy, Xiwen Ma, Kelly Corona, Jean-Richard Saint-Martin, Hua Chang, Yosef Landesman, Anita Joshi, Hongwei Wang, Jatin J. Shah, Sharon Shacham, Michael Kauffman, Éric Van Den Neste, Miguel Canales - The Lancet Haematology 2020 cited by 337

  3. Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

    Authors: Franck Morschhauser, Nathan Fowler, Pierre Feugier, Réda Bouabdallah, Hervé Tilly, M. Lia Palomba, Christophe Fruchart, Edward N. Libby, Olivier Casasnovas, Ian W. Flinn, Corinne Haïoun, Hervé Maisonneuve, Loïc Ysebaert, Nancy L. Bartlett, Kamal Bouabdallah, Pauline Brice, Vincent Ribrag, Nicolas Daguindau, Steven Le Gouill, Gian M. Pica, Alejandro Martı́n, Armando López‐Guillermo, Jean-François Larouche, Kiyoshi Ando, María Gomes da Silva, Marc André, Pierre Zachée, Laurie H. Sehn, Kensei Tobinai, Guillaume Cartron, David Liu, Jianming Wang, Luc Xerri, Gilles Salles - New England Journal of Medicine 2018 cited by 362

  4. Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

    Authors: Pierre Feugier, Ambro van Hoof, Catherine Sebban, P. Solal-Céligny, Réda Bouabdallah, Christophe Fermé, B. Christian, Éric Lepage, Hervé Tilly, Franck Morschhauser, Philippe Gaulard, Gilles Salles, André Bosly, Christian Gisselbrecht, F Reyes, Bertrand Coiffier - Journal of Clinical Oncology 2005 cited by 1,499

  5. Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

    Authors: Marc André, T. Girinsky, Massimo Federico, Oumédaly Reman, Catherine Fortpied, Manuel Gotti, Olivier Casasnovas, Pauline Brice, Richard van der Maazen, Alessandro Re, Véronique Edeline, Christophe Fermé, Gustaaf van Imhoff, Francesco Merli, Réda Bouabdallah, Catherine Sebban, Lena Specht, Aspasia Stamatoullas, Richard Delarue, Valeria Fiaccadori, Monica Bellei, Tiana Raveloarivahy, Annibale Versari, Martin Hutchings, Michel Meignan, John Raemaekers - Journal of Clinical Oncology 2017 cited by 532

  6. High total metabolic tumor volume at baseline predicts survival independent of response to therapy

    Authors: Laëtitia Vercellino, Anne‐Ségolène Cottereau, Olivier Casasnovas, Hervé Tilly, Pierre Feugier, Loïc Chartier, Christophe Fruchart, Louise Roulin, Lucie Obéric, Gian Matteo Pica, Vincent Ribrag, Julie Abraham, Marc A. Simon, Hugo González, Réda Bouabdallah, Olivier Fitoussi, Catherine Sebban, Armando López‐Guillermo, Laurence Sanhès, Franck Morschhauser, Judith Trotman, Bernadette Corront, Bachra Choufi, Sylvia Snauwaert, Pascal Godmer, Josette Brière, Gilles Salles, Philippe Gaulard, Michel Meignan, Catherine Thiéblemont - Blood 2020 cited by 185

  7. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial

    Authors: Gilles Salles, John F. Seymour, Fritz Offner, Armando López‐Guillermo, David Belada, Luc Xerri, Pierre Feugier, Réda Bouabdallah, John Catalano, Pauline Brice, Dolores Caballero, Corinne Haïoun, Lars Møller Pedersen, Alain Delmer, David Simpson, Sirpa Leppä, Pierre Soubeyran, Anton Hagenbeek, Olivier Casasnovas, Tanin Intragumtornchai, Christophe Fermé, María Gomes da Silva, Catherine Sebban, Andrew Lister, Jane Estell, Giuseppe Milone, Anne Sonet, Myriam Mendila, Bertrand Coiffier, Hervé Tilly - The Lancet 2010 cited by 1,066

  8. Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

    Authors: Catherine Thiéblemont, Hervé Tilly, María Gomes da Silva, Olivier Casasnovas, Christophe Fruchart, Franck Morschhauser, Corinne Haïoun, Julien Lazarovici, Anida Grosicka, Aurore Perrot, Judith Trotman, Catherine Sebban, Dolores Caballero, Richard Greil, Koen Van Eygen, Amos Cohen, Hugo González, Réda Bouabdallah, Lucie Obéric, Bernadette Corront, Bachra Choufi, Armando López‐Guillermo, John Catalano, Achiel Van Hoof, Josette Brière, José Cabeçadas, Gilles Salles, Philippe Gaulard, André Bosly, Bertrand Coiffier - Journal of Clinical Oncology 2017 cited by 195

  9. High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group

    Authors: A.-L. Taksin, Ollivier Legrand, Emmanuel Raffoux, Thierry de Revel, Xavier Thomas, Nathalie Contentin, Réda Bouabdallah, Cécile Pautas, Pascal Turlure, Oumédaly Reman, Claude Gardin, Bruno Varet, Stéphane de Botton, Fadela Pousset, H. Farhat, Sylvie Chevret, Hervé Dombret, Sylvie Castaigné - Leukemia 2006 cited by 288

  10. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

    Authors: Eva Hoster, Andreas Rosenwald, Françoise Berger, Heinz‐Wolfram Bernd, Sylvia Hartmann, Christoph Loddenkemper, Thomas F.E. Barth, Nicole Brousse, Stefano Pileri, Grzegorz Rymkiewicz, Roman Kodet, Stephan Stilgenbauer, Roswitha Forstpointner, Catherine Thiéblemont, Michael Hallek, Bertrand Coiffier, Ursula Vehling‐Kaiser, Réda Bouabdallah, Lothar Kanz, Michael Pfreundschuh, Christian Schmidt, Vincent Ribrag, Wolfgang Hiddemann, Michael Unterhalt, Johanna C. Kluin-Nelemans, Olivier Hermine, Martin Dreyling, Wolfgang Hiddemann - Journal of Clinical Oncology 2016 cited by 362

  11. A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy

    Authors: Emmanuel Bachy, Matthew J. Maurer, Thomas M. Habermann, Bénédicte Gelas‐Dore, Delphine Maucort‐Boulch, Jane Estell, Éric Van Den Neste, Réda Bouabdallah, Emmanuel Gyan, Andrew L. Feldman, Joan Bargay, Alain Delmer, Susan L. Slager, María Gomes da Silva, Olivier Fitoussi, David Belada, Hervé Maisonneuve, Tanin Intragumtornchai, Stephen M. Ansell, T. Lamy, Peggy Dartigues, Brian K. Link, John F. Seymour, James R. Cerhan, Gilles Salles - Blood 2018 cited by 206

  12. Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study

    Authors: Vincent Ribrag, Won Seog Kim, Réda Bouabdallah, Soon Thye Lim, Bertrand Coiffier, Árpád Illés, Bernard Lemieux, Martin J.S. Dyer, Fritz Offner, Zakia Felloussi, Ioana Kloos, Ying Luan, Remus Vezan, Thorsten Graef, Franck Morschhauser - Haematologica 2017 cited by 97

  13. Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

    Authors: Michel Attal, Jean-Luc Harousseau, Thierry Façon, François Guilhot, Chantal Doyen, Jean-Gabriel Fuzibet, M. Monconduit, Cyrille Hulin, Denis Caillot, Réda Bouabdallah, Laurent Voillat, Jean-Jacques Sotto, Bernard Bonnotte, Regis Bataille - New England Journal of Medicine 2003 cited by 974

  14. Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study

    Authors: Franck Morschhauser, Steven Le Gouill, Pierre Feugier, Sarah Bailly, Emmanuelle Nicolas‐Virelizier, Fontanet Bijou, Gilles Salles, Hervé Tilly, Christophe Fruchart, Koen Van Eygen, Sylvia Snauwaert, Christophe Bonnet, Corinne Haïoun, Catherine Thiéblemont, Réda Bouabdallah, Ka Lung Wu, Danielle Canioni, Véronique Meignin, Guillaume Cartron, Roch Houot - The Lancet Haematology 2019 cited by 97

  15. Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers

    Authors: Gaëlle Fossard, Florence Broussais, Inês Coelho, Sébastien Bailly, Emmanuelle Nicolas‐Virelizier, Elise Toussaint, Charles Lancesseur, Fabien Le Bras, E. Willems, Emmanuelle Tchernonog, Thomas Chalopin, Richard Delarue, Rémy Gressin, Adrien Chauchet, Emmanuel Gyan, Guillaume Cartron, Christophe Bonnet, Corinne Haïoun, Gandhi Damaj, Philippe Gaulard, Luc Matthieu Fornecker, Hervé Ghesquières, Olivier Tournilhac, María Gomes da Silva, Réda Bouabdallah, Gilles Salles, Emmanuel Bachy - Annals of Oncology 2017 cited by 140

  16. Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

    Authors: Olivier Hermine, Eva Hoster, Jan Walewski, André Bosly, Stephan Stilgenbauer, Catherine Thiéblemont, Michał Szymczyk, Réda Bouabdallah, Michael Kneba, Michael Hallek, Gilles Salles, Pierre Feugier, Vincent Ribrag, Josef Birkmann, Roswitha Forstpointner, Corinne Haïoun, Mathias Hänel, Olivier Casasnovas, Jürgen Finke, Norma Peter, Kamal Bouabdallah, Catherine Sebban, Thomas Fischer, Ulrich Dührsen, Bernd Metzner, Georg Maschmeyer, Lothar Kanz, Christian Schmidt, Richard Delarue, Nicole Brousse, Wolfgang Hiddemann, Elizabeth Macintyre, Marie‐Hélène Delfau‐Larue, Christiane Pott, Wolfgang Hiddemann, Michael Unterhalt, Martin Dreyling - The Lancet 2016 cited by 401

  17. PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study

    Authors: Olivier Casasnovas, Réda Bouabdallah, Pauline Brice, Julien Lazarovici, Hervé Ghesquières, Aspasia Stamatoullas, Jehan Dupuis, Anne‐Claire Gac, Thomas Gastinne, Bertrand Joly, Krimo Bouabdallah, Emmanuelle Nicolas‐Virelizier, Pierre Feugier, Franck Morschhauser, Richard Delarue, H. Farhat, Philippe Quittet, Alina Berriolo-Riedinger, Adrian Tempescul, Véronique Edeline, Hervé Maisonneuve, Luc‐Matthieu Fornecker, Thierry Lamy, Alain Delmer, Peggy Dartigues, Laurent Martin, Marc André, Nicolas Mounier, Alexandra Traverse‐Glehen, Michel Meignan - The Lancet Oncology 2019 cited by 209

  18. Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy

    Authors: Emanuele Zucca, Annarita Conconi, Giovanni Martinelli, Réda Bouabdallah, Alessandra Tucci, Umberto Vitolo, Maurizio Martelli, Ruth Pettengell, Gilles Salles, Catherine Sebban, Armando López Guillermo, Graziella Pinotti, Liliana Devizzi, Franck Morschhauser, Hervé Tilly, Valter Torri, Stefan Hohaus, Andrés J.M. Ferreri, Pierre Zachée, André Bosly, Corinne Haïoun, Caterina Stelitano, Monica Bellei, Maurilio Ponzoni, Anne Moreau, Andrew Jack, Elı́as Campo, Luca Mazzucchelli, Franco Cavalli, Peter Johnson, Catherine Thiéblemont - Journal of Clinical Oncology 2017 cited by 193

  19. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.

    Authors: Camille Laurent, Alina Nicolae, Cécile Laurent, Fabien Le Bras, Corinne Haïoun, Virginie Fataccioli, Nadia Amara, José Adélaı̈de, Arnaud Guillé, Jean-Marc Schiano, Bruno Tesson, Alexandra Traverse‐Glehen, Marie‐Pierre Chenard, Lénaïg Mescam, Anne Moreau, Catherine Chassagne‐Clément, Joan Somja, Fréderic Escudié, Marc André, Nadine Martin, Laetitia Lacroix, François Lemonnier, Anne‐Sophie Hamy, Fabien Reyal, Marie Bannier, Lucie Obéric, Naïs Prade, François-Xavier Frénois, Asma Beldi‐Ferchiou, Marie‐Hélène Delfau‐Larue, Réda Bouabdallah, Daniel Birnbaum, Pierre Brousset, Luc Xerri, Philippe Gaulard - Blood 2019 cited by 121

  20. Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier

    Authors: Cecilia Carpio, Réda Bouabdallah, Loïc Ysebaert, Juan‐Manuel Sancho, Gilles Salles, Raúl Córdoba, Antonio Pinto, Mecide Gharibo, Drew Rasco, Carlos Panizo, José A. López-Martín, Armando Santoro, Antonio Salar, Silvia Damian, Alejandro Martı́n, Gregor Verhoef, Éric Van Den Neste, Maria Wang, Suzana S. Couto, Soraya Carrancio, Andrew P. Weng, Xuehai Wang, Frank Schmitz, Xin Wei, Kristen Hege, Matthew Trotter, Alberto Risueño, Tonia J. Buchholz, Patrick R. Hagner, Anita K. Gandhi, Michael Pourdehnad, Vincent Ribrag - Blood 2020 cited by 73

  21. A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Authors: Vincent Ribrag, Seung‐Tae Lee, David A. Rizzieri, Martin J.S. Dyer, Luis Fayad, Razelle Kurzrock, Leslie A. Andritsos, Réda Bouabdallah, Amjad Hayat, Larry Bacon, Yu Jiang, Kowser Miah, Bruno Delafont, Oday Hamid, S. Anyanwu, Pablo Martínez, Brian Hess - Clinical Lymphoma Myeloma & Leukemia 2020 cited by 28

  22. Treatment of Older Patients with Mantle-Cell Lymphoma

    Authors: Hanneke C. Kluin‐Nelemans, Eva Hoster, Olivier Hermine, Jan Walewski, Marek Trněný, Carsten Geisler, Stephan Stilgenbauer, Catherine Thiéblemont, Ursula Vehling‐Kaiser, Jeanette K. Doorduijn, Bertrand Coiffier, Roswitha Forstpointner, Hervé Tilly, Lothar Kanz, Pierre Feugier, Michał Szymczyk, Michael Hallek, Stephan Kremers, G. Lepeu, Laurence Sanhès, Josée M. Zijlstra, Réda Bouabdallah, Pieternella J. Lugtenburg, Margaret Macro, Michael Pfreundschuh, Vít Procházka, Francesco Di Raimondo, Vincent Ribrag, M. Uppenkamp, Marc André, W. Klapper, W. Hiddemann, Michael Unterhalt, Martin Dreyling - New England Journal of Medicine 2012 cited by 517

  23. Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study

    Authors: Guillaume Cartron, Sophie de Guibert, Marie‐Sarah Dilhuydy, Franck Morschhauser, Véronique Leblond, Jehan Dupuis, Beatrice Mahé, Réda Bouabdallah, Guiyuan Lei, Michael Wenger, Elisabeth Wassner-Fritsch, Michael Hallek - Blood 2014 cited by 148

  24. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study

    Authors: Stéphane Leprêtre, Aurore Touzart, Thomas Vermeulin, Jean‐Michel Picquenot, Aline Schmidt, Gilles Salles, Thierry Lamy, Marie C. Béné, Emmanuel Raffoux, Françoise Huguet, Patrice Chevallier, Serge Bologna, Réda Bouabdallah, Jacques Bénichou, Josette Brière, Anne Moreau, Valérie Tallon-Simon, Stéphanie Seris, Carlos Graux, Vahid Asnafi, Norbert Ifrah, Elizabeth Macintyre, Hervé Dombret - Journal of Clinical Oncology 2015 cited by 97